Factbox: Details of U.S. President Obama’s fiscal year 2015 budget

(Reuters) – U.S. President Barack Obama released his fiscal year 2015 budget request to Congress on Tuesday, and lawmakers will promptly ignore it. Obama outlined how he would parcel out $1.014 trillion on government agencies’ discretionary programs ranging from the military to national parks. The level, barely above this year’s spending cap of $1.012 trillion, was set by a recent budget deal and forces Obama to make some difficult cuts to fund the programs he wants. If the president wants to spend more, he will have to sell Congress on the idea of raising additional revenues.

Massachusetts crime lab tech who faked drug tests was sole ‘bad actor’: state

Annie Dookhan, a former chemist at the Hinton State Laboratory Institute, listens to the judge during her arraignment at Brockton Superior Court in Brockton, MassachusettsBy Scott Malone BOSTON (Reuters) – A former Massachusetts state crime-lab chemist who admitted to faking drug test results was the sole "bad actor" at the facility, but lax management allowed her to carry on for nine years, an official review released on Tuesday concluded. In a case that shook the foundations of the state's criminal justice system, chemist Annie Dookhan last year acknowledged faking tests on evidence in drug cases involving some 40,000 people from 2002 to 2011.

Georgia state lawmakers OK medical marijuana as seizure treatment

A medical marijuana patient smokes inside of Frankie Sports Bar and Grill in OlympiaBy David Beasley ATLANTA (Reuters) – A Georgia measure that would legalize use of a liquid, non-intoxicating form of marijuana for patients with severe seizure disorders has been passed by the state House of Representatives with wide support. Lawmakers approved the legislation on Monday in a 171-4 bipartisan vote, and the bill, which would limit availability of medical marijuana to a handful of research facilities, now goes to the state Senate for consideration. The measure's sponsor, Republican Representative Allen Peake, said he had become interested in the issue after learning about a constituent's 4-year-old daughter, who suffers from a seizure disorder. "I couldn't be more proud of my colleagues for the courageous vote they cast." Medical marijuana in various forms is legal in 20 states.

TSX rises as Ukraine tensions ease, Scotiabank gains

People walk by a sign displaying TSX information in TorontoBy John Tilak TORONTO (Reuters) – Canada's main stock index advanced on Tuesday, with gains in almost every major sector, after comments by Russian President Vladimir Putin helped ease concerns that military conflict in Ukraine was imminent. Providing further support, shares of Bank of Nova Scotia climbed after the lender reported higher quarterly earnings and raised its dividend. While Putin defended Russia's actions in Crimea, global markets took comfort from his statement that military force would be the last resort in Russia's dealings with Ukraine. The Toronto Stock Exchange's S&P/TSX composite index was up 66.03 points, or 0.46 percent, at 14,278.77.

For his next act, Craig Venter takes on human aging

Venter delivers testimony during a hearing on synthetic genomics by the House Energy and Commerce Committee on Capitol Hill in WashingtonBy Julie Steenhuysen La Jolla, California (Reuters) – Craig Venter, the U.S. scientist who raced the U.S. government to map the human genome over a decade ago and created synthetic life in 2010, is now on a quest to treat age-related disease. Venter has teamed up with stem cell pioneer Dr Robert Hariri and X Prize Foundation founder Dr Peter Diamandis to form Human Longevity Inc, a company that will use both genomics and stem cell therapies to find treatments that allow aging adults to stay healthy and functional for as long as possible. "We're hoping to make numerous new discoveries in preventive medicine. The San Diego-based startup company has $70 million in private backing and has already purchased two ultrafast HiSeq X Ten gene sequencing systems from Illumina Inc, a leading manufacturer of DNA sequencing machines, with the option to buy three more.

1 816 817 818 819 820 1,024